1st Aug 2018 07:00
Applied Graphene Materials plc
("Applied Graphene Materials", "AGM", "the Group" or "the Company")
Board Change
Further to the announcement on 29 June 2018, Dr. Adrian Potts has commenced his role as Chief Executive Officer of the Company with effect from today, 1 August 2018. Accordingly, Jon Mabbitt has stepped down from the Board and, as previously announced, will continue in a part time advisory role to support the further development of the Company.
Dr. Bryan Dobson, Non-Executive Chairman of AGM, commented:
"I would like to welcome Adrian to the Board of AGM and look forward to working with him in the next phase of AGM's evolution.
I would also like to take this opportunity to thank Jon for his major contribution to the development of AGM. As CEO he has led the Company from a start-up to an established organisation set to play a key role in the use of graphene in major industrial applications."
Regulatory disclosures
In accordance with Schedule 2(g) of the AIM Rules, Dr. Hugh Adrian Potts (aged 57) holds or has held the following directorships and partnerships:
Current | Past five years |
None | Cytec Process Materials Inc |
Adrian Potts holds 18,109 ordinary shares in the Company.
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
Applied Graphene Materials | +44 (0) 1642 438 214 | |
Bryan Dobson, Chairman | ||
Adrian Potts, Chief Executive Officer | ||
Gareth Jones, Chief Financial Officer | ||
N+1 Singer | +44 (0) 207 496 3000 | |
Richard Lindley / James White | ||
Hudson Sandler | +44 (0) 207 796 4133 | |
Charlie Jack / Emily Dillon |
Notes to Editors
Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group is based at the Wilton Site on Teesside and was admitted to AIM in November 2013, initially raising £11 million.
The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing processes are based on sustainable, readily available raw materials and therefore do not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind these processes.
Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications.
Related Shares:
AGM.L